FDA approves first AI tool to predict breast cancer risk

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.  Read More

​AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.